MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 8.905 USD 19.21% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
MiMedx Group Inc?
Write Note

MiMedx Group Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MiMedx Group Inc
Operating Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
MiMedx Group Inc
NASDAQ:MDXG
Operating Income
$63.4m
CAGR 3-Years
129%
CAGR 5-Years
9%
CAGR 10-Years
51%
Abbvie Inc
NYSE:ABBV
Operating Income
$15.4B
CAGR 3-Years
-5%
CAGR 5-Years
3%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Operating Income
$10.9B
CAGR 3-Years
-3%
CAGR 5-Years
20%
CAGR 10-Years
-1%
Amgen Inc
NASDAQ:AMGN
Operating Income
$6.2B
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Income
$4.3B
CAGR 3-Years
17%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Income
$4.2B
CAGR 3-Years
-18%
CAGR 5-Years
13%
CAGR 10-Years
18%

See Also

What is MiMedx Group Inc's Operating Income?
Operating Income
63.4m USD

Based on the financial report for Sep 30, 2024, MiMedx Group Inc's Operating Income amounts to 63.4m USD.

What is MiMedx Group Inc's Operating Income growth rate?
Operating Income CAGR 10Y
51%

Over the last year, the Operating Income growth was 178%. The average annual Operating Income growth rates for MiMedx Group Inc have been 129% over the past three years , 9% over the past five years , and 51% over the past ten years .

Back to Top